
<!DOCTYPE html>
<!--[if lt IE 9]><html class="no-js lt-ie9" lang="en" dir="ltr"><![endif]-->
<!--[if gt IE 8]><!--><html class="no-js" lang="en" dir="ltr"><!--<![endif]--><head>
                                <meta charset="utf-8">
                                <!-- Web Experience Toolkit (WET) / Boîte à outils de l'expérience Web (BOEW) wet-boew.github.io/wet-boew/License-en.html / wet-boew.github.io/wet-boew/Licence-fr.html -->
								<title>Zika virus - For health professionals</title>
                                <meta content="width=device-width,initial-scale=1" name="viewport">
                                <!-- Meta data-->
                                <!-- Load closure template scripts -->
                                <script type="text/javascript" src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_25/cdts/compiled/soyutils.js"></script>
                                <script type="text/javascript" src="https://www.canada.ca/etc/designs/canada/cdts/gcweb/v4_0_25/cdts/compiled/wet-en.js"></script>

                                <!-- Write closure template -->
                                <script type="text/javascript">
                                                document.write(wet.builder.refTop({
                                                }));
                                </script>
                                <!-- Analytics -->
                                <script>
                                  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
                                  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
                                  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
                                  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

                                  ga('create', 'UA-105628416-1', 'auto');
                                  ga('send', 'pageview');

                                </script>





<link rel="stylesheet" type="text/css" href="../../css/custom.css">



               <meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta charset="utf-8">
<title>Zika virus - Canada.ca</title>

</head>



        <div class="par iparys_inherited">








        <div class="global-header"><!-- Accessibility -->
<ul id="wb-tphp">
    <li class="wb-slc"><a class="wb-sl" href="#wb-cont">Skip to main content</a></li>
    <li class="wb-slc visible-sm visible-md visible-lg"><a class="wb-sl" href="#wb-info">Skip to &#34;About this site&#34;</a></li>

</ul>

<header role="banner">
<div id="wb-bnr" class="container">


    <section id="wb-lng" class="visible-md visible-lg text-right">
    <h2 class="wb-inv">Language selection</h2>
    <div class="row">
        <div class="col-md-12">
            <ul class="list-inline margin-bottom-none">
                <li>
                    <a lang="fr" href="/fr/sante-publique/services/maladies/grippe-influenza.html">
                        Fran&ccedil;ais

                    </a>
                </li>


            </ul>
        </div>
    </div>
</section>
    <div class="row">

        <div class="brand col-xs-8 col-sm-9 col-md-6">
            <a href="/en.html">
                <object type="image/svg+xml" tabindex="-1" data="../../assets/sig-blk-en.svg"></object>
                <span class="wb-inv">Government of Canada</span>
            </a>
        </div>


        <section id="wb-srch" class="col-xs-6 text-right visible-md visible-lg">
            <h2 class="wb-inv">Search</h2>


<form action="../../search-results.html" method="get" name="cse-search-box" role="search" class="form-inline">


<style>

button#wb-srch-sub a:visited {

color: white;


}

</style>


<div class="form-group">
<label for="wb-srch-q" class="wb-inv">Search website</label>
<input name="cdn" value="canada" type="hidden"/>
<input name="st" value="s" type="hidden"/>
<input name="num" value="10" type="hidden"/>
<input name="langs" value="en" type="hidden"/>
<input name="st1rt" value="1" type="hidden"/>
<input name="s5bm3ts21rch" value="x" type="hidden"/>
<input id="wb-srch-q" list="wb-srch-q-ac" class="wb-srch-q form-control" name="q" type="search" value="" size="27" maxlength="150" placeholder="Search Canada.ca"/>
<input type="hidden" name="_charset_" value="UTF-8"/>

<datalist id="wb-srch-q-ac">
<!--[if lte IE 9]><select><![endif]-->
<!--[if lte IE 9]></select><![endif] -->
</datalist>
</div>
<div class="form-group submit">
<button type="submit" id="wb-srch-sub" class="btn btn-primary btn-small" name="wb-srch-sub"><span class="glyphicon-search glyphicon"></span><span class="wb-inv">Search</span></button>

</div>
</form>

        </section>


        <section class="wb-mb-links col-xs-4 col-sm-3 visible-sm visible-xs" id="wb-glb-mn">
            <h2>Search and menus</h2>
            <ul class="list-inline text-right chvrn">
                <li>
                    <a href="#mb-pnl" title="Search and menus" aria-controls="mb-pnl" class="overlay-lnk" role="button">
                <span class="glyphicon glyphicon-search">
                    <span class="glyphicon glyphicon-th-list">
                        <span class="wb-inv">Search and menus</span>
                    </span>
                </span>
                    </a>
                </li>
            </ul>
            <div id="mb-pnl"></div>
        </section>
    </div>
</div>


<nav role="navigation" id="wb-sm" data-ajax-replace="../../ajax/sitemenu-en.html" data-trgt="mb-pnl" class="wb-menu visible-md visible-lg" typeof="SiteNavigationElement">
<div class="container nvbar">
<h2>Topics menu</h2>
<div class="row">
<ul class="list-inline menu">
<li><a href="http://www.esdc.gc.ca/en/jobs/index.page">Jobs</a></li>
<li><a href="http://www.cic.gc.ca/english/index.asp">Immigration</a></li>
<li><a href="https://travel.gc.ca/">Travel</a></li>
<li><a href="https://www.canada.ca/en/services/business.html">Business</a></li>
<li><a href="https://www.canada.ca/en/services/benefits.html">Benefits</a></li>
<li><a href="http://healthycanadians.gc.ca/index-eng.php">Health</a></li>
<li><a href="https://www.canada.ca/en/services/taxes.html">Taxes</a></li>
<li><a href="https://www.canada.ca/en/services.html">More services</a></li>
</ul>
</div>
</div>
</nav>



    <nav role="navigation" id="wb-bc" property="breadcrumb"><h2 class="wb-inv">You are here:</h2><div class="container"><div class="row"><ol class="breadcrumb">
<li class="cust-breadcrumb"><a href='../../en.html'>Home</a></li>
<li class="cust-breadcrumb">...</li>
<li class="cust-breadcrumb"><a href='../../services/diseases.html'>Diseases</a></li>
</ol></div></div></nav>




</header>




<div data-ajax-replace="/bin/canada/alert/messages.en.html" class="original"></div>
</div>



</div>




<main role="main" property="mainContentOfPage" class="container gc-advnc-srvc">
<h1 property="name" id="wb-cont">Zika virus: For health professionals</h1>

<div class="gc-stp-stp">
<div class="row">
<ul class="toc lst-spcd col-md-12">

  <li class="col-md-4 col-sm-6"><a class="list-group-item" href="./zika-virus.html">Symptoms and treatment</a></li>
<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./zika-pregnant-planning.html">Pregnant or planning</a></li>
<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./zika-travelling.html">Destinations with risk of Zika</a></li>
<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./zika-prevention.html">Prevention and risks</a></li>
<li class="col-md-4 col-sm-6"><a class="list-group-item cust-active active" href="./zika-professionals.html">For health professionals</a></li>
<li class="col-md-4 col-sm-6"><a class="list-group-item" href="./zika-notices.html">Latest travel advice</a></li>

</ul>

</div>
</div>
<div class="row">
<section class="col-md-8">
  <h2 style="margin-top: -18px;">For health professionals</h2>
<h3 class="onpage" style="margin-top: -5px;">On this page</h3>

<ul>
 <li><a href="#a">What health professionals need to know about Zika virus</a></li>
 <li><a href="#b">Agents of disease</a></li>
 <li><a href="#c">Clinical manifestations</a></li>
 <li><a href="#a4">Spectrum of clinical illness</a></li>
 <li><a href="#a5">Testing</a></li>
 <li><a href="#a6">Diagnosis</a></li>
  <li><a href="#a7">Treatment</a></li>
  <li><a href="#_Has_Zika_virus">Surveillance in Canada</a></li>
  <li><a href="#Zika_canada">Zika cases in Canada</a></li>
 <li><a href="#_How_does_Canada">How Canada monitors Zika</a></li>
 <li><a href="#_How_many_cases">Zika around the world</a></li>
 <li><a href="#g">Related information</a></li>
 <li><a href="#p">Posters to share</a></li>
</ul>



<h3 class="th3" id="a">What health professionals need to know about the Zika virus</h3>
<p>The Zika virus is a neurotropic virus that is capable of entering the nervous system and targets neural progenitor cells. The Zika virus is transmitted primarily as a mosquito-borne infection; it can also be transmitted sexually.</p>
<p>Exposure to the Zika virus during fetal development increases the risk of severe health outcomes, such as Congenital Zika Syndrome.  For this reason, travellers to Zika affected countries or areas should wait before trying to conceive:</p>
<ul>
  <li class="bullet"><strong>6 months</strong> after returning, if you are a couple or a man. Couples should practice abstinence or use barrier methods, for example, using condoms correctly.</li>
  <li class="bullet"><strong>2 months</strong> after you return, if you are a woman and your male partner did not travel with you.</li>
</ul>
<p>Male travellers who have a pregnant partner should:</p>
<ul>
  <li class="bullet"><strong>always </strong>use a condom correctly, or </li>
  <li class="bullet">avoid having sex for the duration of the pregnancy</li>
</ul>
<p>To help advise your patients who are planning to travel, you may want to: </p>
<ul>
  <li class="bullet">consult <a href="./zika-travelling.html">current and ongoing Zika-affected countries or areas</a></li>
  <li class="bullet">inform travellers about <a href="https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2012-38/statement-on-personal-protective-measures-prevent-arthropod-bites.html">mosquito bite prevention measures </a></li>
</ul>
<p>For additional detail, review CATMAT’s <a href="/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-5-may-5-2016/ccdr-volume-42-5-may-5-2016-zika-virus.html">Recommendations on the Prevention and Treatment of Zika Virus for Canadian health care professionals</a>. </p>


<h3 class="th3" id="b">Agent of disease</h3>
<p>The Zika virus is a single stranded RNA flavivirus and a member of the Flaviviridae family.</p>
<p>There are at least 2 Zika virus lineages which are the:</p>
<ul>
  <li class="bullet">Asian lineage</li>
  <li class="bullet">African lineage</li>
</ul>
<p>A recent study suggests there may be three geographically distinct viral lineages (African I and II, and Asian), however much is still unknown about the evolution and diversity of Zika virus. The Asian lineage strain has recently emerged in the Pacific and the Americas.</p>
<p>Aedes aegypti is:</p>
<ul>
  <li>the primary vector of Zika virus</li>
  <li>largely restricted to tropical and subtropical regions, though temperate populations may occur in isolated refuges </li>
</ul>
<p>Aedes albopictus has been implicated as a vector, though its role in the current outbreak is uncertain. This species is widely present outside the tropics.</p>
<p>A small number of the Aedes aegypti and Aedes albopictus species have recently been found in Windsor, Ontario. It is not known whether populations of these species have become established in Windsor.Studies are on-going to define the risk from the recent introduction of these two mosquito species into this part of Ontario.</p>
<p>Currently, the mosquitoes that transmit the Zika virus are not established in Canada due to the climate. So, there is a very low probability of mosquito transmission in Canada.</p>
<p>These two species of mosquito are the same type of mosquito that can carry and transmit <a href="https://wwww.canada.ca/en/public-health/services/infectious-diseases/viral-haemorrhagic-fevers/dengue-fever/symptoms.html">dengue</a> virus and <a href="https://www.canada.ca/en/public-health/services/diseases/chikungunya.html">chikungunya</a> virus.</p>
<p>The Zika virus is in the same family of viruses that cause:</p>
<ul>
  <li class="bullet">dengue</li>
  <li class="bullet">West Nile</li>
  <li class="bullet">St. Louis encephalitis </li>
  <li class="bullet">Japanese encephalitis</li>
</ul>


<h3 class="th3"  id="c"Clinical manifestations</h3>
<p>Asymptomatic infections are common. Only 1 in 4 people infected with Zika virus are believed to develop symptoms.</p>
<p>The main symptoms of Zika virus infection include:</p>
<ul>
  <li class="bullet">retro-orbital pain </li>
  <li class="bullet">low-grade fever (less than 38.5°C) </li>
  <li class="bullet">general non-specific symptoms, such as:
    <ul>
      <li>myalgia</li>
      <li>asthenia</li>
      <li>headaches </li>
    </ul>
  </li>
  <li class="bullet">transient arthritis or arthralgia with possible joint swelling
    <ul>
      <li>mainly in the smaller joints of the hands and feet</li>
    </ul>
  </li>
  <li class="bullet">maculopapular rash often spreading from the face to the body </li>
  <li class="bullet">conjunctival hyperaemia or bilateral non-purulent conjunctivitis</li>
</ul>
<p>The incubation period ranges from 3 to 14 days. The symptoms are usually mild and last for 2 to 7 days. Most people recover fully without severe complications and only require simple supportive care. Hospitalization rates are low.</p>
<p>Infection may go unrecognized or be misdiagnosed as:</p>
<ul>
  <li class="bullet">dengue</li>
  <li class="bullet">chikungunya</li>
  <li class="bullet">other viral infections causing fever and rash</li>
</ul>


<h3 class="th3" id="a4">Spectrum of clinical illness</h3>
<p>Congenital Zika Syndrome involves a spectrum of neurological and other developmental deficits, including but not limited to:</p>
<ul>
  <li class="bullet">hearing loss</li>
  <li class="bullet">club foot and arthrogryposis </li>
  <li class="bullet">abnormal brain development including:
    <ul>
      <li>microcephaly</li>
      <li>cerebral atrophy</li>
      <li>callosal hypoplasia </li>
      <li>diffuse subcortical calcification </li>
      <li>abnormal cortical development</li>
    </ul>
  </li>
  <li class="bullet">vision impairment and ocular anomalies such as:
    <ul>
      <li>cataracts </li>
      <li>micropthamia</li>
      <li>retinal abnormalities </li>
    </ul>
  </li>
  <li class="bullet">other neurologic abnormalities including:
    <ul>
      <li>seizures </li>
      <li>spasticity</li>
      <li>irritability </li>
    </ul>
  </li>
</ul>
<p>A number of countries have reported a correlation between infection with the Zika virus the development of <a href="http://apps.who.int/iris/bitstream/10665/252762/1/zikasitrep5Jan17-eng.pdf?ua=1">Guillain-Barré Syndrome</a> (GBS). This is being further investigated through research studies.</p>
<p>A small number of deaths associated with Zika virus infection have been reported. These are being observed in:</p>
<ul>
  <li class="bullet">infants with severe congenital anomalies</li>
  <li class="bullet">older adults with multiple comorbidities</li>
</ul>
<p>Birth defects were reported in similar proportions of fetuses/infants whose mothers did and did not report symptoms during pregnancy. Defects were reported among all trimesters, although there was a higher likelihood if the mother was infected during the first trimester.</p>
<p>Recent findings from the US Zika Pregnancy registry (United States and United States Territories) found that approximately 1 in 20 fetuses or infants whose mothers had Zika virus infection during pregnancy had congenital anomalies.</p>
<p>When analysis was restricted to confirmed Zika virus infections in the first trimester, approximately 1 in 10 fetuses or infants had a possible Zika virus-associated congenital anomaly.</p>




<h3 class="th3" id="a5">Testing</h3>
<p>The decision to offer Zika testing to adults is described in the decision-tree for Zika virus laboratory testing.</p>
<p>Decisions to test should consider:</p>
<ul>
  <li class="bullet">travel history</li>
  <li class="bullet">populations at risk</li>
  <li class="bullet">presence of symptoms consistent with Zika virus infection</li>
  <li class="bullet">possible non-travel related exposures, for example, sexual transmission </li>
</ul>
<p>The choice of the optimal test, including timing and modality, are explained more fully in the diagnostics section.</p>
<p>The workup for potential Zika virus infection in pediatric patients, particularly infants born to mothers affected in pregnancy, can involve some additional non-laboratory testing.</p>
<p>Please refer to the Canadian Paediatric Society “<a href="https://www.cps.ca/en/documents/position/Zika-virus" rel="external">Practice Point”, March 30, 2017</a> for guidance.</p>
<h4 id="decision-tree">Decision-tree for Zika Virus Laboratory Testing</h4>


</div>
<div class="mwsadaptiveimage textimage parbase section">




<figure>




        <img src="./1516217557913.jpg" alt="" class="img-responsive cq-dd-image" data-emptytext="Image"/>






</figure>
</div>


<div class="mwsaccordion-html section">






    <details>
        <summary>Text equivalent</summary>
        <div class="mwsbodytext text parbase section">



        <p>This image is a decision-tree intended to help health care providers make decisions related to Zika virus laboratory testing.</p>
<p class="mrgn-rght-lg">1. The first question relates to the risk population: is the patient male or female?</p>
<h3>Male or non-pregnant female patient</h3>
<p>If the patient is male or a non-pregnant female</p>
<p class="mrgn-rght-lg">2. Do they have a travel history or a sexual partner with a travel history to a place reporting local mosquito-borne transmission of Zika virus infection?</p>
<p>If the answer is “no,” testing for Zika virus infection is not recommended. Zika virus infection is unlikely without travel or exposure history.</p>
<p>Other infectious diseases with similar signs and symptoms are possible. Additional infectious diseases work-up may be warranted. If unsure about the relevance or scope of work-up, consider consulting with an infectious diseases specialist.</p>
<p class="mrgn-rght-lg">3. If the answer is “yes” for travel history for the male or non-pregnant female, choose from 3 options:</p>
<ol class="lst-upr-alph">
<li class="bullet">“The patient is experiencing acute symptoms consistent with Zika virus infection.”</li>
<li class="bullet">“The patient was previously symptomatic consistent with Zika virus infection and the symptoms have now resolved.”</li>
<li class="bullet">“The patient has had no symptoms consistent with Zika virus infection.”</li>
</ol>
<p>If the answer is “yes” for travel history for the male or non-pregnant female <strong>and:</strong></p>
<p>3.A&nbsp; that patient is experiencing acute symptoms consistent with Zika virus infection, testing is recommended.</p>
<p>If the answer is “yes” for travel history for the male or non-pregnant female <strong>and:</strong></p>
<p>3.B&nbsp; the patient was previously symptomatic consistent with Zika virus infection and the symptoms have now resolved, testing should be considered <strong>if</strong> a confirmed diagnosis would be helpful.</p>
<p>In some instances, such as couples trying to conceive where pregnancy cannot be delayed for medical reasons, testing may be warranted. In such cases, we recommend consulting with an infectious diseases specialist.</p>
<p>If the answer is “yes” for travel history for the male or non-pregnant female <strong>and:</strong></p>
<p>3.C&nbsp; if the patient has had no symptoms consistent with a Zika virus infection, testing is not routinely recommended.</p>
<p>As with the previous example, some individual cases may warrant testing. We recommend consulting with an infectious diseases specialist.</p>




</div>


    </details>




</div>
<div class="mwsbodytext text parbase section">



        <h4>Decision-tree for Zika Virus Laboratory Testing</h4>




</div>
<div class="mwsadaptiveimage textimage parbase section">




<figure>




        <img src="./1516217558015.jpg" alt="" class="img-responsive cq-dd-image" data-emptytext="Image"/>






</figure>
</div>
<div class="mwsaccordion-html section">






    <details>
        <summary>Text equivalent<br>
</summary>
        <div class="mwsbodytext text parbase section">



        <h3>Pregnant female patient</h3>
<p>If the patient is a pregnant female</p>
<p class="mrgn-rght-lg">1. Does she have a travel history or a sexual partner with travel history to a place reporting local mosquito-borne transmission of Zika virus infection?</p>
<p>If the answer is “no”, then testing for Zika virus infection is not recommended. Zika virus infection is unlikely without travel or exposure history.</p>
<p>Other infectious diseases with similar signs and symptoms are possible. Additional infectious diseases work-up may be warranted. If unsure about the relevance or scope of work up, consider consulting with an infectious diseases specialist.</p>
<p class="mrgn-rght-lg">2. If the answer is “yes” for travel history or a sexual partner with travel history to a place reporting local mosquito-borne transmission of Zika virus infection for the pregnant female, choose from 3 options:</p>
<ol class="lst-upr-alph">
<li class="bullet">“The patient is experiencing acute symptoms consistent with Zika virus infection.”</li>
<li class="bullet">“The patient was previously symptomatic consistent with Zika virus infection and the symptoms have now resolved.”</li>
<li class="bullet">“The patient has had no symptoms consistent with Zika virus infection.”</li>
</ol>
<p>If the patient is a pregnant female <strong>and</strong> the answer is “yes” for travel history or a sexual partner with a travel history to a place reporting local mosquito-borne transmission of Zika virus infection <strong>and:</strong></p>
<p>2.A&nbsp; the patient is experiencing acute symptoms consistent with Zika virus infection, testing is recommended.</p>
<p>If the patient is a pregnant female <strong>and</strong> the answer is “yes” for travel history or sexual partner with travel history to a place reporting local mosquito-borne transmission of Zika virus infection <strong>and:</strong></p>
<p>2.B&nbsp; if the patient was previously symptomatic consistent with Zika virus infection and the symptoms have now resolved, testing is recommended.</p>
<p>If the patient is a pregnant female <strong>and</strong> the answer is “yes” for travel history or sexual partner with travel history to a place reporting local mosquito-borne transmission of Zika virus infection <strong>and:</strong></p>
<p>2.C if the patient has had no symptoms consistent with a Zika virus infection, testing is a consideration.</p>
<p>The absence of symptoms does not predict risk of Congenital Zika Syndrome. Due to the complexity of interpretation and timelines of pregnancy, you should consult early with an infectious diseases specialist before testing is considered.</p>




</div>


    </details>





<div class="row col-md-8" style="padding-top: 15px">


    <h3 id="a6">Diagnosis</h3>
<p>Laboratory diagnosis is usually accomplished by testing serum or plasma to detect any of the following:</p>
<ul>
  <li class="bullet">viral genetic material (ribonucleic acid, RNA)</li>
  <li class="bullet">virus-specific antibodies produced by the body</li>
</ul>
<p>There are 2 testing methods available for detecting Zika virus: polymerase chain reaction (PCR) testing and serology testing.</p>
<h3>Polymerase chain reaction (PCR) testing</h3>
<p>This test directly detects the genetic material of the Zika virus. A positive result confirms the patient has a Zika virus infection.</p>
<p>The PCR assay is most effective when testing clinical specimens such as:</p>
<ul>
  <li class="bullet">blood collected within 10 days of start of symptoms</li>
  <li class="bullet">urine collected within 14 days of start of symptoms</li>
</ul>
<p>The major limitation of this test is that Zika virus may only be present in these types of specimens for a short time after the start of an infection.</p>
<h3>Serology testing</h3>
<p>Instead of testing for components of the virus, these tests are able to detect the presence of Zika virus antibodies. Antibodies become detectable approximately one week post-symptom onset.</p>
<p>The major advantage of a serology test is that it remains positive for several months or longer after infection.</p>
<p>The major limitations are that it:</p>
<ul>
  <li class="bullet">may take several days or weeks to perform and report back results</li>
  <li class="bullet">is prone to cross-react with antibodies that target other similar flaviviruses related to Zika virus, including the dengue virus. A positive result may represent a previous exposure to another virus or a past vaccination for viruses such as yellow fever, making interpretation difficult.</li>
</ul>
<h3>Testing considerations</h3>
<p>PCR and serology tests, if positive, can be used to confirm a Zika virus infection.</p>
<h3>PCR</h3>
<p>A positive PCR test for Zika virus signifies an acute infection despite mild symptoms.</p>
<p>A negative PCR test for Zika virus may mean:</p>
<ul>
  <li class="bullet">there was no infection</li>
  <li class="bullet">the individual was infected but the virus was no longer present when the sample was collected. Subsequent serological testing is recommended to confirm a case. </li>
</ul>
<h3>Serology</h3>
<p>An initial positive serological result may represent:</p>
<ul>
  <li class="bullet">an acute infection or previous exposure to Zika virus</li>
  <li class="bullet">an acute infection or previous exposure to another flavivirus</li>
  <li class="bullet">past vaccination for other viruses, such as yellow fever</li>
</ul>
<p>Identifying and confirming Zika virus-specific antibodies in serum samples may require further testing and, in some cases, collecting additional samples. This is due to possible cross-reactivity of serologic tests with antibodies that relate to other similar flaviviruses such as dengue virus.</p>
<p>A negative serological test for Zika could mean:</p>
<ul>
  <li class="bullet">antibodies have yet to develop</li>
  <li class="bullet">there was no infection, which may warrant the collection of additional samples</li>
</ul>
<p>A negative serology test performed 1 to 2 months following return from travel would indicate that there was no infection, because antibodies usually develop within 4 weeks following exposure. If the health care provider suspects the test was performed too early, a second blood sample may be collected for additional testing.</p>
<p>Patients should be aware of these test limitations and accept that results may not be available for a number of weeks.</p>


<h3 id="a7">Treatment</h3>
<p>Currently, there is no prophylaxis, vaccine or treatment for Zika virus infection. Treatment may be directed toward symptom relief, such as:</p>
<ul>
  <li class="bullet">rest</li>
  <li class="bullet">fluids</li>
  <li class="bullet">analgesics
    <ul>
      <li>avoid acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs until dengue infection has been eliminated as a possibility</li>
    </ul>
  </li>
  <li class="bullet">antipyretics</li>
</ul>





<h3 id="_Has_Zika_virus">Surveillance in Canada</h3>

<p>The Public Health Agency of Canada and provincial and territorial partners work closely to conduct national surveillance on Zika virus cases in Canada. </p>
<p>Health professionals in Canada play a critical role in identifying cases of Zika virus infection. Health professionals who have questions should contact their local public health authorities for further details.</p>
<p>The National Microbiology Laboratory performs testing to detect the virus and offers testing support to provinces and territories. Some provincial laboratories also offer testing.</p>

<h3 id="Zika_canada">Zika cases in Canada</h3>

<p>As of December 1, 2017, 544 travel-related cases and 4 sexually transmitted cases have been reported in Canada since cases started being detected in October 2015. &nbsp;A total of 37 cases have been reported amongst pregnant women in Canada and 2 newborns with Zika-related anomalies have been reported. </p>
<p>Since pregnancy outcomes (including births, stillbirths, pregnancy loss and terminations) are not reported to public health authorities, pregnancy outcomes for Zika-infected women are not generally known. Surveillance activities are focused on detecting the number of cases of Congenital Zika Syndrome (those with observable Zika-related anomalies).</p>
<p>There is ongoing low risk to Canadians travelling to <a href="./zika-travelling.html">countries or areas in the U.S. with reported mosquito-borne transmission of Zika virus</a>.</p>
<p>Twenty-five case were reported for the period of September 1 – November 30, 2017, of these only 2 were confirmed as having an illness onset date in that time frame (others had an onset date prior to September 1, 2017, or no onset date was provided). All of these 25 cases were travel associated.</p>
<p>The data will be updated quarterly. The next update will be made in March 2018.</p>
<div class="parbase section table">
 <div class="table-bravo" id="acctable221">
  <table class="table table-bordered">
   <caption class="text-left">
     Zika cases detected in Canada, between June 2015 and December 1, 2017
   </caption>
   <tbody>
    <tr>
     <th scope="col">Acquired through sexual transmission</th>
     <th scope="col">Travel-related</th>
    </tr>
    <tr>
     <td>4</td>
     <td>544</td>
    </tr>
   </tbody>
  </table>
 </div>
</div>

<h3 id="_How_does_Canada">How Canada monitors Zika</h3>
<p>The National Microbiology Laboratory is able to detect the virus and offers testing support to provinces and territories. Some provincial labs also conduct testing.</p>
<p>As part of their <a href="https://www.canada.ca/en/public-health/services/diseases/west-nile-virus/west-nile-virus-other-mosquito-borne-disease.html">West Nile virus surveillance programs</a>, several provinces and territories conduct mosquito surveillance activities.</p>
<p>Planning is underway to enhance mosquito surveillance to detect an introduction of new mosquito species into Canada. This would include those species responsible for Zika virus transmission.</p>

<h3 id="_How_many_cases">Zika virus around the world</h3>
<p>The virus was first identified in humans in the 1950s. From 1951 through 1981, evidence of human Zika virus infection was reported from African countries and in parts of Asia.</p>
<p>In 2007, the first major outbreak of Zika virus occurred in Micronesia (Yap Island) in the southwestern Pacific Ocean. This was the first time that Zika virus was detected outside of Africa and Asia.</p>
<p>Between 2013 and 2015, several significant outbreaks were noted on islands and archipelagos from the Pacific region. This included a large outbreak in French Polynesia.</p>
<p>In early 2015, Zika virus emerged in South America with widespread outbreaks reported in Brazil and Colombia.</p>
<p>The World Health Organization monitors Zika case reports from around the world. To date, a number of countries, territories and areas have reported cases of microcephaly and/or central nervous system malformation potentially associated with Zika virus infection. Monitoring of pregnant women in other countries experiencing Zika virus outbreaks is ongoing.</p>



  <h3 id="g">Related information</h3>

 <ul class="mrgn-tp-md">


  <li class="bullet">Committee to Advise on Tropical Medicine and Travel
    <ul>
      <li><a href="/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-5-may-5-2016/ccdr-volume-42-5-may-5-2016-zika-virus.html">Canadian Recommendations on the Prevention and Treatment of Zika Virus</a></li>
      <li><a href="/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2012-38/statement-on-personal-protective-measures-prevent-arthropod-bites.html">Statement on Personal Protective Measures to Prevent Arthropod Bites</a></li>
    </ul>
  </li>
  <li class="bullet"><a href="http://www.cps.ca/en/documents/position/Zika-virus" rel="external">Canadian Paediatric Society, Practice Point</a></li>
  <li class="bullet"><a href="http://www.who.int/csr/don/en/" rel="external">World Health Organization: Disease Outbreak News</a></li>
  <li class="bullet"><a href="http://www.paho.org/Hq/index.php?option=com_topics&amp;view=article&amp;id=427&amp;Itemid=41484&amp;lang=en" rel="external">Pan American Health Organization: Zika virus infection</a></li>
  <li class="bullet"><a href="http://www.cdc.gov/zika/" rel="external">U.S. Centers for Disease Control and Prevention: Zika virus</a></li>

 </ul>



  <h3 id="p">Posters to share</h3>

 <ul class="mrgn-tp-md">
   <li class="bullet"><a href="http://healthycanadians.gc.ca/publications/diseases-conditions-maladies-affections/zika-virus-counselling-travelers-conseiller-voyageurs/index-eng.php">Zika virus: Counselling travellers</a> (poster)</li>
   <li class="bullet"><a href="http://healthycanadians.gc.ca/publications/diseases-conditions-maladies-affections/zika-virus-info-health-prof-renseignements-prof-sante/index-eng.php">Zika virus: Information for health professionals</a> (poster)</li>
 </ul>
</div>


</div>

</div>




</section>

<div class="clearfix"></div>
<nav role="navigation" class="mrgn-bttm-lg">
<h3 class="wb-inv">Document navigation</h3>
<ul class="pager">
<li class="next"><a href="./zika-notices.html" rel="next">Next<span class="wb-inv"></span></a></li>
<li class="previous"><a href="./zika-prevention.html" rel="prev">Previous<span class="wb-inv"></span></a></li>
</ul>
</nav>
</section>

</div>



<div class="row pagedetails">

    <details class="brdr-0 col-sm-6 col-lg-4 mrgn-tp-sm">

<summary class="btn btn-default text-center">Report a problem or mistake on this page</summary>
<div class="clearfix"></div>
<div class="well row">
    <div><div class="gc-rprt-prblm">
    <div class="gc-rprt-prblm-frm gc-rprt-prblm-tggl">
        <section id="privacy" class="mfp-hide modal-dialog modal-content overlay-def">
            <header class="modal-header">
                <h2 class="modal-title">Privacy statement</h2>
            </header>
        </section>

    </div>

</div></div>
</div>

    </details>

        <div class="col-sm-3 mrgn-tp-sm pull-right">
        <div class="wb-share" data-wb-share='{&#34;lnkClass&#34;: &#34;btn btn-default btn-block&#34;}'></div>
    </div>


    <div class="datemod col-xs-12 mrgn-tp-lg">
        <dl id="wb-dtmd">
    <dt>Date modified:</dt>
    <dd><time property="dateModified">2018-01-03</time></dd>
</dl>
    </div>
</div>



</main>



        <div class="par iparys_inherited">




    <!-- Write closure template -->
                                </main>
                                <div id="def-footer">

                                </div>
                                <!-- Write closure template -->
                                <script type="text/javascript">
                                                var defFooter = document.getElementById("def-footer");
                                                defFooter.outerHTML = wet.builder.footer({
                                                                showFooter: true,
                                                                showFeatures: false
                                                });
                                </script>
                                <!-- Write closure template -->
                                <script type="text/javascript">
                                                document.write(wet.builder.refFooter({
                                                }));
                                </script>


</body>
</html>
